Effect of Annona muricata L. (Soursop) on Blood Glucose Level in a Diabetic Rat Model: A Meta-Analysis

Main Article Content

Rahmad Darmawan
Ira Humairah
Ema Qunianingsih
Ervi A. Munthe
Linda

Abstract

Annona muricata L. (soursop) is a plant rich in bioactive compounds and has been extensively studied for its potential antidiabetic and antioxidant properties. However, findings across studies have been inconsistent regarding its efficacy. This meta-analysis aims to synthesize and evaluate the available scientific evidence to draw reliable conclusions about the effectiveness and underlying mechanisms of A. muricata in managing diabetes mellitus. Relevant studies were retrieved from three major scientific databases: PubMed, Scopus, and Web of Science. The analysis included studies that reported blood glucose levels in diabetic rodent models treated with A. muricata extract. Statistical analysis revealed that supplementation with A. muricata extract significantly reduced blood glucose levels (SMD = –7.05; 95% CI: –11.22 to –4.61; p < 0.00001) in diabetic rats compared to control groups. These findings indicate that A. muricata has a significant hypoglycemic effect and holds promise as a potential therapeutic agent for diabetes management.

Downloads

Download data is not yet available.

Article Details

Section

Articles

Author Biography

Rahmad Darmawan, Master Program of Basic Medical Sciences, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Kediri, Indonesia.

How to Cite

Effect of&nbsp;Annona muricata&nbsp;L. (Soursop) on Blood Glucose Level in a Diabetic Rat Model: A Meta-Analysis. (2025). Tropical Journal of Natural Product Research , 9(9), 4148 – 4154. https://doi.org/10.26538/tjnpr/v9i9.11

References

1.Popoviciu MS, Paduraru L, Nutas RM, Ujoc AM, Yahya G, Metwally K, Cavalu S. Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities. Int J Mol Sci 2023;24. https://doi.org/10.3390/ijms241612676.

2.Mills H, Acquah R, Tang N, Cheung L, Klenk S, Glassen R, Pirson M, Albert A, Hoang DT, Van TN. Type 2 Diabetes Mellitus (T2DM) and Carbohydrate Metabolism in Relation to T2DM from Endocrinology, Neurophysiology, Molecular Biology, and Biochemistry Perspectives. Evidence-Based Complement Altern Med 2022;2022. https://doi.org/10.1155/2022/1708769.

3.Al-Rasheed NM, Al-Rasheed NM, Bassiouni YA, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mahmoud AM. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes. Biomed Pharmacother 2018;105:290–8. https://doi.org/10.1016/j.biopha.2018.05.130.

4.Dahlén AD, Dashi G, Maslov I, Attwood MM, Jonsson J, Trukhan V, Schiöth HB. Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales. Front Pharmacol 2022;12:1–16. https://doi.org/10.3389/fphar.2021.807548.

5.Dhirani D, Shahid A, Mumtaz H. A new kind of diabetes medication approved by the FDA: is there hope for obesity? Int J Surg 2023;109:81–2. https://doi.org/10.1097/JS9.0000000000000044.

6.Mihailović M, Dinić S, Jovanović JA, Uskoković A, Grdović N, Vidaković M. The influence of plant extracts and phytoconstituents on antioxidant enzymes activity and gene expression in the prevention and treatment of impaired glucose homeostasis and diabetes complications. Antioxidants 2021;10:1–25. https://doi.org/10.3390/antiox10030480.

7.Zarvandi M, Rakhshandeh H, Abazari M, Shafiee-Nick R, Ghorbani A. Safety and efficacy of a polyherbal formulation for the management of dyslipidemia and hyperglycemia in patients with advanced-stage of type-2 diabetes. Biomed Pharmacother 2017;89:69–75. https://doi.org/10.1016/j.biopha.2017.02.016.

8.Pang GM, Li FX, Yan Y, Zhang Y, Kong LL, Zhu P, Wang KF, Zhang F, Liu B, Lu C. Herbal medicine in the treatment of patients with type 2 Diabetes mellitus. Chin Med J (Engl) 2019;132:78–85. https://doi.org/10.1097/CM9.0000000000000006.

9.Moghadamtousi SZ, Fadaeinasab M, Nikzad S, Mohan G, Ali HM, Kadir HA. Annona muricata (Annonaceae): A review of its traditional uses, isolated acetogenins and biological activities. Int J Mol Sci 2015;16:15625–58. https://doi.org/10.3390/ijms160715625.

10.Zubaidi SN, Mohd Nani H, Ahmad Kamal MS, Abdul Qayyum T, Maarof S, Afzan A, Mohmad Misnan N, Hamezah HS, Baharum SN, Mediani A. Annona muricata: Comprehensive Review on the Ethnomedicinal, Phytochemistry, and Pharmacological Aspects Focusing on Antidiabetic Properties. Life 2023;13. https://doi.org/10.3390/life13020353.

11.Alsenosy AWA, El-Far AH, Sadek KM, Ibrahim SA, Atta MS, Sayed-Ahmed A, Al Jaouni SK, Mousa SA. Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats. PLoS One 2019;14:1–18. https://doi.org/10.1371/journal.pone.0222410.

12.Florence NT, Benoit MZ, Jonas K, Alexandra T, Désiré DDP, Pierre K, Théophile D. Antidiabetic and antioxidant effects of Annona muricata (Annonaceae), aqueous extract on streptozotocin-induced diabetic rats. J Ethnopharmacol 2014;151:784–90. https://doi.org/10.1016/j.jep.2013.09.021.

13.Al Syaad KM, Elsaid FG, Abdraboh ME, Al-Doaiss AA. Effect of graviola (Annona Muricata l.) and ginger (Zingiber Officinale Roscoe) on Diabetes mellitus induced in male wistar albino rats. Folia Biol (Czech Republic) 2019;65:275–84. https://doi.org/10.14712/fb2019065050275.

14.Leonardo R. PICO : Model for Clinical Questions Evidence Based Medicine and Practice PICO : Model for Clinical Questions. Evid Based Med 2018;3:1–2. https://doi.org/10.4172/2471-9919.1000115.

15.Chen KY, Ma B, Wang YN, Chen CH, Zhao YQ, Zheng JX, Huang C Ben, Zhang LS, Su X, Yang JH, Wei GQ, Zheng DX, Wang XY, Zhu QG, Wang YP, Qin Q. SYRCLE’s risk of bias tool for animal studies. Chinese J Evidence-Based Med 2014;14:1281–5. https://doi.org/10.7507/1672-2531.20140206.

16.Adewole SO, Ojewole JAO. Protective effects of Annona muricata Linn. (Annonaceae) leaf aqueous extract on serum lipid profiles and oxidative stress in hepatocytes of streptozotocin-treated diabetic rats. African J Tradit Complement Altern Med 2009;6:30–41. https://doi.org/10.4314/ajtcam.v6i1.57071.

17.Ojo OA, Grant S, Amanze JC, Oni AI, Ojo AB, Elebiyo TC, Obafemi TO, Ayokunle DI, Ogunlakin AD. Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic β-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes. PLoS One 2022;17:1–22. https://doi.org/10.1371/journal.pone.0276984.

18.Omiyale BO, Ekundayo BE, Mathenjwa-Goqo MS, Ajiboye BO, Oyinloye BE. Protective effect of phenolic-rich extract of Anona muricata Linn leaf on renal oxidative stress and inflammation in streptozotocin-induced diabetes in diabetic rats. Sci African 2025;27:e02515. https://doi.org/10.1016/j.sciaf.2024.e02515.

19.Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. vol. 94. Springer Berlin Heidelberg; 2020. https://doi.org/10.1007/s00204-020-02693-7.

20.Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Neurol 2014;4:1–10. https://doi.org/10.3389/fphar.2013.00177.

21.Agu KC, Okolie NP, Falodun A, Engel-Lutz N. In vitro anticancer assessments of Annona muricata fractions and in vitro antioxidant profile of fractions and isolated acetogenin (15-acetyl guanacone). J Cancer Res Pract 2018;5:53–66. https://doi.org/10.1016/j.jcrpr.2017.12.001.

22.Lam TP, Tran NVN, Pham LHD, Lai NVT, Dang BTN, Truong NLN, Nguyen-Vo SK, Hoang TL, Mai TT, Tran TD. Flavonoids as dual-target inhibitors against α-glucosidase and α-amylase: a systematic review of in vitro studies. Nat

Products Bioprospect 2024;14. https://doi.org/10.1007/s13659-023-00424-w.

23.Alwan IA, Lim V, Samad NA, Widyawati T, Yusoff NA. Current Research in Nutrition and Food Science Effect of Annona Muricata L . on Metabolic Parameters in Diabetes Mellitus : A Systematic Review. Curr Res Nutr Food Sci 2020;08:1–11.

24.Han M, Lu Y, Tao Y, Zhang X, Dai C, Zhang B, Xu H, Li J. Luteolin Protects Pancreatic β Cells against Apoptosis through Regulation of Autophagy and ROS Clearance. Pharmaceuticals 2023;16:1–17. https://doi.org/10.3390/ph16070975.

25.Liu H, Zhou W, Guo L, Zhang H, Guan L, Yan X, Zhai Y, Qiao Y, Wang Z, Zhao J, Lyu K, Li P, Wang H, Peng L. Quercetin protects against palmitate-induced pancreatic β-cell apoptosis by restoring lysosomal function and autophagic flux. J Nutr Biochem 2022;107:1–11. https://doi.org/10.1016/j.jnutbio.2022.109060.